AGUSTONI, FRANCESCO
AGUSTONI, FRANCESCO
Universita' degli Studi di MILANO
A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small cell lung cancer
2021 A. Bruni, V. Scotti, P. Borghetti, S. Vagge, S. Cozzi, E. D'Angelo, N. Giaj Levra, A. Fozza, M. Taraborrelli, G. Piperno, V. Vanoni, M. Sepulcri, M. Trovo, V. Nardone, E. Lattanzi, S. Bou Selman, F. Bertolini, D. Franceschini, F. Agustoni, B.A. Jereczek-Fossa, S.M. Magrini, L. Livi, F. Lohr, A.R. Filippi
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors
2015 D. Serpico, A. Trama, E.R. Haspinger, F. Agustoni, L. Botta, R. Berardi, G. Palmieri, P. Zucali, R. Gallucci, M. Broggini, G. Gatta, U. Pastorino, G. Pelosi, F. De Braud, M.C. Garassino
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
2011 M. Platania, F. Agustoni, B. Formisano, M. Vitali, M. Ducceschi, F. Pietrantonio, N. Zilembo, F. Gelsomino, S. Pusceddu, R. Buzzoni
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC) : An Italian, Multicenter, Retrospective Study
2020 A. Luciani, A. Marra, L. Toschi, D. Cortinovis, S. Fava, V. Filipazzi, A. Tuzi, G. Cerea, S. Rossi, V. Perfetti, A. Rossi, L. Giannetta, L. Sala, G. Finocchiaro, E.G. Pizzutilo, S. Carelli, F. Agustoni, M. Cergnul, S. Zonato, S. Siena, P. Bidoli, D. Ferrari
Emerging toxicities in the treatment of non-small cell lung cancer : ocular disorders
2014 F. Agustoni, M. Platania, M. Vitali, N. Zilembo, E. Haspinger, V. Sinno, R. Gallucci, F. De Braud, M.C. Garassino
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer
2015 M. Platania, B. Valeri, A. Marchianò, G. Calareso, F. Agustoni, E. Haspinger, S. Pusceddu, M.C. Garassino, F. Gelsomino, F. de Braud
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)
2023 S. Cavalieri, V. Vitolo, A. Barcellini, S. Ronchi, A. Facoetti, C. Campo, C. Klersy, S. Molinelli, F. Agustoni, V.V. Ferretti, A. Silvestri, M. Platania, M.D. Vecchio, M. Durante, A. Helm, C. Fournier, F. Braud, P. Pedrazzoli, E. Orlandi, L. Licitra
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? : Analysis of a phase II trial
2013 S. Damian, L. Celio, E. De Benedictis, P. Mariani, F. Agustoni, F. Ricchini, F. De Braud
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
2016 D. Signorelli, M. Macerelli, C. Proto, M. Vitali, M.S. Cona, F. Agustoni, N. Zilembo, M. Platania, A. Trama, R. Gallucci, M. Ganzinelli, G. Pelosi, U. Pastorino, F. De Braud, M.C. Garassino, G. Lo Russo